277 related articles for article (PubMed ID: 17543391)
1. Neuroactive steroids and peripheral neuropathy.
Roglio I; Giatti S; Pesaresi M; Bianchi R; Cavaletti G; Lauria G; Garcia-Segura LM; Melcangi RC
Brain Res Rev; 2008 Mar; 57(2):460-9. PubMed ID: 17543391
[TBL] [Abstract][Full Text] [Related]
2. Peripheral nerves: a target for the action of neuroactive steroids.
Melcangi RC; Cavarretta IT; Ballabio M; Leonelli E; Schenone A; Azcoitia I; Miguel Garcia-Segura L; Magnaghi V
Brain Res Brain Res Rev; 2005 Apr; 48(2):328-38. PubMed ID: 15850671
[TBL] [Abstract][Full Text] [Related]
3. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
[TBL] [Abstract][Full Text] [Related]
4. Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells.
Magnaghi V; Veiga S; Ballabio M; Gonzalez LC; Garcia-Segura LM; Melcangi RC
J Peripher Nerv Syst; 2006 Jun; 11(2):111-8. PubMed ID: 16787508
[TBL] [Abstract][Full Text] [Related]
5. Chapter 15: Novel pharmacological approaches to Schwann cells as neuroprotective agents for peripheral nerve regeneration.
Magnaghi V; Procacci P; Tata AM
Int Rev Neurobiol; 2009; 87():295-315. PubMed ID: 19682644
[TBL] [Abstract][Full Text] [Related]
6. Neuroactive steroids: A therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events.
Leonelli E; Ballabio M; Consoli A; Roglio I; Magnaghi V; Melcangi RC
J Mol Neurosci; 2006; 28(1):65-76. PubMed ID: 16632876
[TBL] [Abstract][Full Text] [Related]
7. Neuroactive steroids and peripheral myelin proteins.
Magnaghi V; Cavarretta I; Galbiati M; Martini L; Melcangi RC
Brain Res Brain Res Rev; 2001 Nov; 37(1-3):360-71. PubMed ID: 11744100
[TBL] [Abstract][Full Text] [Related]
8. Nidogen is a prosurvival and promigratory factor for adult Schwann cells.
Lee HK; Seo IA; Park HK; Park YM; Ahn KJ; Yoo YH; Park HT
J Neurochem; 2007 Aug; 102(3):686-98. PubMed ID: 17437540
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats.
Pesaresi M; Maschi O; Giatti S; Garcia-Segura LM; Caruso D; Melcangi RC
Horm Behav; 2010 Jan; 57(1):46-55. PubMed ID: 19422828
[TBL] [Abstract][Full Text] [Related]
10. Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy.
Mitro N; Cermenati G; Brioschi E; Abbiati F; Audano M; Giatti S; Crestani M; De Fabiani E; Azcoitia I; Garcia-Segura LM; Caruso D; Melcangi RC
J Steroid Biochem Mol Biol; 2014 Sep; 143():115-21. PubMed ID: 24607810
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury.
Roglio I; Bianchi R; Gotti S; Scurati S; Giatti S; Pesaresi M; Caruso D; Panzica GC; Melcangi RC
Neuroscience; 2008 Aug; 155(3):673-85. PubMed ID: 18625290
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic approaches to peripheral neuropathy based on neuroactive steroids.
Melcangi RC; Garcia-Segura LM
Expert Rev Neurother; 2006 Aug; 6(8):1121-5. PubMed ID: 16893339
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes.
Caruso D; Scurati S; Maschi O; De Angelis L; Roglio I; Giatti S; Garcia-Segura LM; Melcangi RC
Neurochem Int; 2008; 52(4-5):560-8. PubMed ID: 17686551
[TBL] [Abstract][Full Text] [Related]
14. Neuroactive steroids and the peripheral nervous system: An update.
Giatti S; Romano S; Pesaresi M; Cermenati G; Mitro N; Caruso D; Tetel MJ; Garcia-Segura LM; Melcangi RC
Steroids; 2015 Nov; 103():23-30. PubMed ID: 25824325
[TBL] [Abstract][Full Text] [Related]
15. Sex-specific therapeutic strategies based on neuroactive steroids: In search for innovative tools for neuroprotection.
Cosimo Melcangi R; Garcia-Segura LM
Horm Behav; 2010 Jan; 57(1):2-11. PubMed ID: 19524584
[TBL] [Abstract][Full Text] [Related]
16. Neuroactive steroids prevent peripheral myelin alterations induced by diabetes.
Veiga S; Leonelli E; Beelke M; Garcia-Segura LM; Melcangi RC
Neurosci Lett; 2006 Jul; 402(1-2):150-3. PubMed ID: 16626861
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model.
Roglio I; Bianchi R; Camozzi F; Carozzi V; Cervellini I; Crippa D; Lauria G; Cavaletti G; Melcangi RC
J Peripher Nerv Syst; 2009 Mar; 14(1):36-44. PubMed ID: 19335538
[TBL] [Abstract][Full Text] [Related]
18. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
[TBL] [Abstract][Full Text] [Related]
19. Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating age-dependent dysfunctions of peripheral nerves.
Melcangi RC; Azcoitia I; Ballabio M; Cavarretta I; Gonzalez LC; Leonelli E; Magnaghi V; Veiga S; Garcia-Segura LM
Prog Neurobiol; 2003 Sep; 71(1):57-66. PubMed ID: 14611868
[TBL] [Abstract][Full Text] [Related]
20. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
Fortun J; Go JC; Li J; Amici SA; Dunn WA; Notterpek L
Neurobiol Dis; 2006 Apr; 22(1):153-64. PubMed ID: 16326107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
